- ESMO 2025: Patient Reported Outcomes from AMPLITUDE, a Trial of Niraparib and Abiraterone Acetate plus Prednisone in mHSPC with Homologous Recombination Repair Mutations UroToday
- Niraparib Combo Boosts rPFS in Metastatic HRR-Altered CSPC CancerNetwork
- JnJ gets USFDA priority review for Akeega plus prednisone for prostate cancer Medical Dialogues
- New Drug Combination May Reduce Risk of Prostate Cancer Progression Healthgrades Health Library
- New drug combination offers hope for men with advanced prostate cancer: Study Medical Dialogues
Despite overall increases in cancer screening, such as mammography for breast cancer, some geographic areas in the U.S. still show low screening rates, a study published October 17 in JAMA Network Open found.
Researchers led by Pranoti Pradhan,…